The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiotic therapy.

The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiotic therapy.

Item
http://www.wikidata.org/entity/Q34289714
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults.Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.Influence of pharmacokinetics/pharmacodynamics of antibacterials in their dosing regimen selection.Interpretation of antibiotic concentration ratios measured in epithelial lining fluid.Comparison of the pharmacodynamics of biapenem in bronchial epithelial lining fluid in healthy volunteers given half-hour and three-hour intravenous infusionsTreatment of pulmonary exacerbations in adult cystic fibrosis patients: a review.Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.How to minimize toxic exposure to pyridine during continuous infusion of ceftazidime in patients with cystic fibrosis?In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.Efficacy of clarithromycin against experimentally induced pneumonia caused by clarithromycin-resistant Haemophilus influenzae in mice.Single-dose azithromycin for acute otitis media: a pharmacokinetic/pharmacodynamic rationale.In vitro pharmacokinetic and pharmacodynamic evaluation of S-013420 against Haemophilus influenzae and Streptococcus pneumoniae.Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
P2860

The hidden impact of antibacterial resistance in respiratory tract infection. Re-evaluating current antibiotic therapy.

Item
http://www.wikidata.org/entity/Q34289714
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The hidden impact of antibacte ...... ng current antibiotic therapy.
@ast
The hidden impact of antibacte ...... ng current antibiotic therapy.
@en
The hidden impact of antibacte ...... ng current antibiotic therapy.
@nl
type
label
The hidden impact of antibacte ...... ng current antibiotic therapy.
@ast
The hidden impact of antibacte ...... ng current antibiotic therapy.
@en
The hidden impact of antibacte ...... ng current antibiotic therapy.
@nl
prefLabel
The hidden impact of antibacte ...... ng current antibiotic therapy.
@ast
The hidden impact of antibacte ...... ng current antibiotic therapy.
@en
The hidden impact of antibacte ...... ng current antibiotic therapy.
@nl
P1433
P1476
P2093
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
The hidden impact of antibacte ...... ng current antibiotic therapy.
@en
P2093
P304
P31
P356
10.1016/S0954-6111(01)90023-X
P478
P577
P698
P921